MIPLYFFA Momentum and Pipeline Upside Support Zevra Therapeutics Buy Rating
at www.tipranks.com (Fri, 6-Nov 2:35 PM)
at www.tipranks.com (Thu, 5-Nov 7:20 AM)
Zevra Therapeutics (ZVRA) Receives a Buy from BTIG
at www.tipranks.com (Thu, 5-Nov 6:16 AM)
Zevra Therapeutics: Analyst Maintains $20 Price Target on Miplyffa Momentum and Celiprolol Upside
at www.tipranks.com (Wed, 4-Nov 12:45 PM)
Cantor Fitzgerald Keeps Their Buy Rating on Zevra Therapeutics (ZVRA)
at www.tipranks.com (Wed, 4-Nov 10:45 AM)
Analyst Maintains Buy Rating and $26 Price Target as MIPLYFFA Growth Accelerates
at www.tipranks.com (Wed, 4-Nov 8:27 AM)
Zevra Therapeutics, Inc. GAAP EPS of $0.26 beats by $0.11, revenue of $37.8M beats by $0.39M
at seekingalpha.com (Tue, 3-Nov 4:32 PM)
